Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 2/17: (SRPT) (MU) (CCG) Upgraded; (IMAX) (CVC) (JWN) Downgraded
-
UPDATE: Canaccord Genuity Downgrades IMAX Corporation (IMAX) to Hold
-
Ultragenyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Canaccord Genuity Starts Box, Inc. (BOX) at Hold
-
Stryker (SYK) Can Get a Smith & Nephew (SNN) Deal Done at $45/Share - Canaccord Genuity
-
Cognex (CGNX) PT Lifted to $55 at Canaccord Genuity on 'Solid' Q4
-
Zynga (ZNGA) PT Cut to $2.50 at Canaccord Genuity
-
ReWalk Robotics (RWLK) PT Cut at $17 at Canaccord Genuity
-
RTI Biologics (RTIX) PT Lifted to $7 at Canaccord Genuity
-
Digital Realty Trust (DLR) PT Bumped to $72 at Canaccord Genuity
-
Klox Technologies (KLOX) Files for $75M IPO
-
Notable Analyst Rating Changes 2/12: (ALLY) (CPA) (MOS) Upgraded; (TSLA) (FTI) (ZU) Downgraded
-
Transition Therapeutics (TTHI) Prices 3.08M Share Offering at $6.50/Sh
-
Canaccord Genuity Downgrades Zulily, Inc (ZU) to Hold
-
Transition Therapeutics (TTHI) to Offer Common Stock
-
Akamai (AKAM) PT Raised to $75 at Canaccord Genuity Amid Strong Q4; Sees 'Beat-and-Raise' Type Year Ahead
-
Notable Analyst Rating Changes 2/10: (STJ) (C) (TE) Upgraded; (RIG) (BPZ) (GPS) Downgraded
-
Canaccord Genuity Upgrades Tahoe Resources (TAHO) to Buy
-
Canaccord Genuity Starts Pernix Therapeutics (PTX) at Buy
-
Using History as a Guide, Weakness in American Tower (AMT) is a Buying Opportunity - Canaccord Genuity
-
Apple (AAPL) Price Target Lifted to $145 at Canaccord Genuity
-
Notable 52-Week Highs and Lows 2/6: (NXPI) (FTR) (LNKD) High; (P) (NOV) (MXWL) Low
-
NXP Semiconductors (NXPI) PT Raised to $97 at Canaccord Genuity
-
Ultragenyx Pharmaceutical (RARE) 3M Offering Prices at $54/Share
-
Notable Analyst Rating Changes 2/4: (SFUN) (SYK) (EXPR) Upgraded; (GDP) (GTE) (BBEP) Downgraded
-
Pre-Open Stock Movers 02/04: (NES) (ENTR) (SJM) Higher; (RL) (GLID) (SPLS) Lower (more...)
-
Spirit AeroSystems (SPR) PT Raised to $60 at Canaccord Genuity
-
Continental Resources (CLR) PT Raised to $54 at Canaccord Genuity
-
Canaccord Genuity Downgrades Goodrich Petroleum (GDP) to Hold
-
Ultragenyx Pharmaceutical (RARE) to Offer $125M in Common Stock
-
Canaccord Genuity Sees Solid Q4 Report for Under Armour (UA)
-
UPDATE: Canaccord Genuity Downgrades Michael Kors (KORS) to Hold
-
PhotoMedex (PHMD) Announces $40M Sale of LCA-Vision Subsidiary
-
Notable Analyst Rating Changes 1/30: (JASO) (YHOO) (FL) Upgraded; (DGX) (APPY) (CX) Downgraded
-
Avinger (AVGR) IPO Opens Modestly Higher
-
Avinger (AVGR) Prices 5M Common IPO at $13/Share, Middle of Expected Range
-
Canaccord Genuity Downgrades AspenBio Pharma (APPY) to Hold
-
Notable 52-Week Highs and Lows 01/29: (JBLU) (BA) (HAR) High; (QCOM) (GEVO) (APPY) Low
-
Entellus Medical (ENTL) IPO Opens Up 13%
-
Neovasc (NVCN) Increases Size of Stock Offering Due to Interest, 10.5M Prices at $7.19/Share
-
Boeing (BA) PT Lifted to $160 at Canaccord Genuity
-
Facebook (FB) Raised to $90 at Canaccord Genuity
-
Canaccord Cuts PT on Stratasys (SSYS) to $120 Ahead of FY15 Commentary
-
This Higher-End Shoe Name Could Bolster Steven Madden (SHOO) Offerings - Canaccord
-
Synergy Resources (SYRG) Prices 16.2M Share Offering at $10.75/Share
-
SAGE Therapeutics Announces Participation in February Conferences
-
Notable Analyst Rating Changes 1/27: (SCSS) (EGO) (VA) Upgraded; (MSFT) (STO) (DHI) Downgraded
-
Marinus Pharmaceuticals to Participate in Canaccord Genuity Rare Disease Biopharma Day
-
Canaccord Genuity Upgrades Eldorado Gold Corp (EGO) to Hold
-
Canaccord Genuity Downgrades Rogers Communications (RCI) to Hold


